The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
pfizer just released data uh showing high levels of efficacy in adolescence 12 to 15. um but there were small numbers there was around 1200 and the vaccine grew 1200 in the control group uh and there were 18 cases of covet in the in the control group none in the vaccinated group and on that basis and their press releases had 100 efficacy i'm sure that won't hold up i mean yeah it's too small a number
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.